[Abstract] Megakaryocytes are the precursor cells of platelets and are bona fide resident cells in the bone marrow but extremely low in numbers (~1% of total nucleated cells). Upon terminal differentiation, megakaryocytes increase their size, become polyploid and develop a demarcation membrane system. Mature megakaryocytes form proplatelets, which are cytoplasmic extensions that protrude through the endothelial cell layer of venous sinusoids within the bone marrow, entering into the blood circulation and, subsequently, releasing platelets. Despite limited in numbers, megakaryocytes have been successfully isolated from bone marrow (Tolhurst et al., 2012) , adult peripheral blood (Mazur et al., 1990; Thornton et al., 1999) , cord blood (Sun et al., 2004) and also from embryonic stem cells (Pick et al., 2013; Eto et al., 2002) . These procedures rely on immunostaining using antibodies against megakaryocyte surface markers (i.e. CD41 or CD42b) to isolate an enriched population of megakaryocytes. Here, we describe a culture method wherein megakaryocytes can be grown and differentiated in vitro from human peripheral blood mononuclear cells (PBMCs) directly without the need of initial isolation of CD34 + cells. This method is based on a previously published culture method of human erythroid progenitor cells from PBMCs (Borg et al., 2010; Leberbauer et al., 2005) . Although the purity of megakaryocytes is not 100% in this culture method, an enriched fraction of megakaryocytes can be further isolated using BSA gradient or cell-sorting techniques. In addition, our method offers the possibility to freeze the cultures after minimal expansion of yet undifferentiated megakaryocytes, which will yield equal megakaryocyte cultures after thawing when compared to fresh uninterrupted cultures. As this has been proven difficult with CD34 + sorted pluripotent cells, it allows managing samples and to perform downstream analysis when human material is not always available.
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Materials and Reagents
Note: *These materials/reagents can be replaced by similar alternatives. Start with approximately 50 ml of whole blood, recently collected using a closed system (sterile) from a healthy donor or a patient by a trained phlebotomist under consent. It is advisable to start the culture on the day of collection, but 1-2 days after extraction is also possible (although with donor variation). We normally use citrate phosphate dextrose, but EDTA and heparin are also compatible with this method.
2. Centrifuge blood at 300 x g (1,000 rpm) for 15 min (using brake 3) at room temperature. 9. Wash/refresh the culture at day 3-4 if necessary, and re-culture in fresh medium, or dilute in ½ volume of Phase I medium, depending on cell numbers, which should not http://www.bio-protocol.org/e1639 Figures 2B and 3B ).
13. There will be appearance of bigger cells in the culture at day 13-14 or earlier and there should be gradually increasing numbers of these cells. Observe the culture every day, because depending on donor, some megakaryocytes will undergo terminal differentiation and start forming proplatelets, which implies losing cells due to cell death as well. Morphology and growth is subject to donor variability. It is estimated that from a starting culture with 50 x 10 6 cells, there will be around 50 x 10 6 megakaryocytes in average, with donor variation. This means that the culture first expands 2-4 times, and then, only 25-50% of the cells mature into megakaryocytes.
See Figure 2 for an overview of the dynamics of the culture in terms of morphology and surface marker expression as measured by flow cytometer.
http://www.bio-protocol.org/e1639 (Figure 3 ).
Optional complementary techniques
Materials and Reagents TPO 100 ng/ml
